Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Phenoptin™ in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of Phenoptin in individuals with phenylketonuria completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• Phenoptin

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Phenylketonurias | Phase 3 | Status: COMPLETED | Results posted: 2009-04-16